BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Gorchs L, Kaipe H. Interactions between Cancer-Associated Fibroblasts and T Cells in the Pancreatic Tumor Microenvironment and the Role of Chemokines. Cancers (Basel) 2021;13:2995. [PMID: 34203869 DOI: 10.3390/cancers13122995] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
Number Citing Articles
1 Lefler JE, MarElia-Bennett CB, Thies KA, Hildreth BE 3rd, Sharma SM, Pitarresi JR, Han L, Everett C, Koivisto C, Cuitino MC, Timmers CD, O'Quinn E, Parrish M, Romeo MJ, Linke AJ, Hobbs GA, Leone G, Guttridge DC, Zimmers TA, Lesinski GB, Ostrowski MC. STAT3 in tumor fibroblasts promotes an immunosuppressive microenvironment in pancreatic cancer. Life Sci Alliance 2022;5:e202201460. [PMID: 35803738 DOI: 10.26508/lsa.202201460] [Reference Citation Analysis]
2 Malinova A, Veghini L, Real FX, Corbo V. Cell Lineage Infidelity in PDAC Progression and Therapy Resistance. Front Cell Dev Biol 2021;9:795251. [PMID: 34926472 DOI: 10.3389/fcell.2021.795251] [Reference Citation Analysis]
3 Bannoura SF, Uddin MH, Nagasaka M, Fazili F, Al-Hallak MN, Philip PA, El-Rayes B, Azmi AS. Targeting KRAS in pancreatic cancer: new drugs on the horizon. Cancer Metastasis Rev 2021;40:819-35. [PMID: 34499267 DOI: 10.1007/s10555-021-09990-2] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
4 Bhatia R, Bhyravbhatla N, Kisling A, Li X, Batra SK, Kumar S. Cytokines Chattering in Pancreatic Ductal Adenocarcinoma Tumor Microenvironment. Semin Cancer Biol 2022:S1044-579X(22)00077-3. [PMID: 35346801 DOI: 10.1016/j.semcancer.2022.03.021] [Reference Citation Analysis]
5 Hung YH, Chen LT, Hung WC. The Trinity: Interplay among Cancer Cells, Fibroblasts, and Immune Cells in Pancreatic Cancer and Implication of CD8+ T Cell-Orientated Therapy. Biomedicines 2022;10:926. [PMID: 35453676 DOI: 10.3390/biomedicines10040926] [Reference Citation Analysis]
6 Tatekawa S, Ofusa K, Chijimatsu R, Vecchione A, Tamari K, Ogawa K, Ishii H. Methylosystem for Cancer Sieging Strategy. Cancers (Basel) 2021;13:5088. [PMID: 34680237 DOI: 10.3390/cancers13205088] [Reference Citation Analysis]
7 Manoukian P, Bijlsma M, van Laarhoven H. The Cellular Origins of Cancer-Associated Fibroblasts and Their Opposing Contributions to Pancreatic Cancer Growth. Front Cell Dev Biol 2021;9:743907. [PMID: 34646829 DOI: 10.3389/fcell.2021.743907] [Reference Citation Analysis]
8 Narayanan S, Vicent S, Ponz-sarvisé M. PDAC as an Immune Evasive Disease: Can 3D Model Systems Aid to Tackle This Clinical Problem? Front Cell Dev Biol 2021;9:787249. [DOI: 10.3389/fcell.2021.787249] [Reference Citation Analysis]
9 De P, Aske J, Sulaiman R, Dey N. Bête Noire of Chemotherapy and Targeted Therapy: CAF-Mediated Resistance. Cancers 2022;14:1519. [DOI: 10.3390/cancers14061519] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
10 Mun JY, Leem SH, Lee JH, Kim HS. Dual Relationship Between Stromal Cells and Immune Cells in the Tumor Microenvironment. Front Immunol 2022;13:864739. [PMID: 35464435 DOI: 10.3389/fimmu.2022.864739] [Reference Citation Analysis]